Chapters

Transcript

Video

The Role of Locoregional and Systemic Therapies in the Management of Colorectal Liver Metastases

The Role of Locoregional and Systemic Therapies in the Management of Colorectal Liver Metastases

Somewhere around 50 percent of patients with colon cancer spread to the liver cannot be treated surgically. The hepatic artery pump is a highly effective way to get them to a point where they can undergo surgery,” says Jason Castellanos, MD, assistant professor, Fox Chase Department of Surgical Oncology.

In this video, Dr. Castellanos explains the role of surgical resection in the management of liver-confined metastatic colorectal cancer and using hepatic artery infusion pump (HAIP) chemotherapy for treating resectable and unresectable colorectal liver metastases.

Topics include:

  • Epidemiology of Colorectal Liver Metastases (CRLM)
  • Role of Liver Resection for CRLM
  • HAIP for Unresectable CRLM
  • HAIP for Adjuvant Therapy

Related Presenters

Jason Castellanos, MD, MS, FACS.

Jason Castellanos, MD, MS, FACS

Assistant Professor, Fox Chase Department of Surgical Oncology

Treatment Focus Cancers of the liver, gall bladder, bile ducts, and pancreas; Colorectal liver metastases; Hepatic artery infusion pump chemotherapy; Robotic surgery; Minimally invasive surgery.

View full profile